Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Bevacizumab and Carboplatin for Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
- Status
- COMPLETED
- Phase
- PHASE2
First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Chemoradiation Treatment for Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2